Transcept Pharmaceuticals (TSPT)
Transcept Pharmaceuticals Stock Buybacks
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
TSPT Stock Buybacks Range, Past 5 Years
| Minimum | 0.00 | Jun 2009 |
| Maximum | 0.026M | Sep 2009 |
| Average | 0.013M |
About Stock Buybacks
Stock buybacks occur when companies buy back their own stock, removing it from the marketplace. Stock buybacks can increase the value of the remaining shares because company earnings are split among fewer shares.
Buybacks are sometimes an indication that a company perceives their stock to be undervalued, but it is up to the investor to determine if the company is correct.
Learn More
You may also be interested in these TSPT related companies
TSPT News
$TSPT http://stks.co/40nB Got a quick 10% off TSPT from May 22 watchlist!
about 3 days ago by RalfKaiser
about 3 days ago by RalfKaiser
$TSPT Mentioned more than normal on StockTwits - Currently at 5 x average daily social activity
about 7 days ago by TradeIdeasQuant
about 7 days ago by TradeIdeasQuant
RT @HighGrowthFinancial $TSPT Breakout, been posting since down .6% good looking out brother easy money
about 7 days ago by Newbie_Trader
about 7 days ago by Newbie_Trader
@fhmmax $ARNA you are right. Found it on here! "
$TSPT seeks $40.5M in public offering to advance OCD candidate TO-2061, shares slide 14%"
about 17 days ago by BiopharmaPro
about 17 days ago by BiopharmaPro
$TSPT Mentioned more than normal on StockTwits - Currently at 10 x average daily social activity
about 17 days ago by TradeIdeasQuant
about 17 days ago by TradeIdeasQuant
@fhmmax $ARNA dropped on $TSPT doing a stock dilution? did they say how many shares and at what price when it dropped?
about 17 days ago by BiopharmaPro
about 17 days ago by BiopharmaPro
$AMRN $TSPT raised to outperfom http://stks.co/3pO3{372423ee-fd5e-490b-8081-ee1361c10014}
about 17 days ago by fhmmax
about 17 days ago by fhmmax
Listen to $TSPT Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3ono
about 18 days ago by earningscast
about 18 days ago by earningscast
Transcept Pharmaceuticals, (TSPT) Posts Wider than Expected Q1 Loss of 37c/Share
May 14, 4:03PM Street Insider
May 14, 4:03PM Street Insider
Transcept Pharmaceuticals to Present at Two Upcoming Investor Conferences
May 09, 6:58AM PR Newswire
May 09, 6:58AM PR Newswire
$TSPT wonder why the secondary? the conference call implied Purdue as $$ Facility, not shareholders. Waitin for $7.50-80
about 25 days ago by HighGrowthFinancial
about 25 days ago by HighGrowthFinancial
Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
Apr 16, 4:35PM PR Newswire
Apr 16, 4:35PM PR Newswire
Transcept Pharmaceuticals Announces National Product Launch of Intermezzo® by Purdue Pharma L.P.
Apr 05, 6:38AM Benzinga
Apr 05, 6:38AM Benzinga
Transcept (TSPT) Reports New Dosages of Intermezzo Available for Prescription
Apr 05, 6:27AM Street Insider
Apr 05, 6:27AM Street Insider
Transcept Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
Mar 14, 4:03PM PR Newswire
Mar 14, 4:03PM PR Newswire
Transcept Pharmaceuticals to Present at Two Upcoming Investor Conferences
Feb 29, 8:03AM PR Newswire
Feb 29, 8:03AM PR Newswire
JMP Securities Starts Transcept Pharmaceuticals (TSPT) at Market Outperform
Feb 10, 8:22AM Street Insider
Feb 10, 8:22AM Street Insider
Transcept Pharmaceuticals to Present at Two Upcoming Investor Conferences
Feb 07, 8:05AM PR Newswire
Feb 07, 8:05AM PR Newswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TSPT | 7.08 | -0.02 | -0.28% | 98.69M |
| TSON | 2.93 | -0.05 | -1.68% | 81.20M |
| TSO | 22.12 | -1.09 | -4.70% | 3.265B |
| TSM | 13.73 | -0.20 | -1.44% | 72.20B |
| TNB | 71.99 | +0.00 | +0.00% | 3.758B |
| TNAV | 6.01 | +0.20 | +3.44% | 241.81M |
| TNA | 47.26 | -0.31 | -0.65% | |
| TMX | 15.33 | +0.00 | +0.00% | |
| TMS | 11.10 | -0.37 | -3.23% | |
| TMP | 36.61 | +0.01 | +0.03% | 408.46M |
